Epinephrine Prices June 2023
Product
|
Category |
Region |
Price |
Epinephrine |
Pharma API |
USA |
2,000 USD/Kg |
Epinephrine |
Pharma API |
China |
2,000 USD/Kg |
Epinephrine |
Pharma API |
Germany |
3,000 USD/Kg |
The price of epinephrine in the United States for June 2023 reached 2,000 USD/Kg. Similarly, the price trend for epinephrine in China reached 2,000 USD/Kg in June 2023. Whereas the June 2023 epinephrine price was 3,000 USD/Kg in the Germany.
Epinephrine Price Trend, Market Analysis, and News
IMARC’s newly published report, titled “Epinephrine Pricing Report 2024: Price Trend, Chart, Market Analysis, News, Demand, Historical and Forecast Data,” offers an in-depth analysis of epinephrine pricing, covering an analysis of global and regional market trends and the critical factors driving these price movements.
It encompasses an in-depth review of spot price of epinephrine at major ports, a breakdown of prices including Ex Works, FOB, and CIF, alongside a region-wise dissection of epinephrine price trend across North America, Europe, Asia Pacific, Latin America, the Middle East and Africa.
The report examines the elements influencing epinephrine price fluctuations, such as changes in raw material costs, supply-demand dynamics, geopolitical factors, and industry-specific developments. Additionally, it integrates the latest market news, providing stakeholders with up-to-date information on market shifts, regulatory changes, and technological advancements, thereby offering a comprehensive overview that aids in strategic decision-making and forecasting.
Epinephrine Market Analysis
The global epinephrine market size reached US$ 3.1 Billion in 2023. By 2032, IMARC Group expects the market to reach US$ 6.4 Billion, at a projected CAGR of 8.4% during 2023-2032.
- The rising number of allergies across the globe is driving the need for epinephrine auto-injectors to manage severe allergic reactions, such as anaphylaxis. Furthermore, the epinephrine demand is amplified by expanding its use in emergency medicine for conditions such as cardiac arrest, severe asthma attacks, and anaphylaxis. To treat severe allergic conditions due to insect stings, medicines, or foods, it is highly preferable, as it can reverse the symptoms rapidly and stop the reaction.
- The increasing awareness among healthcare professionals and the public about the signs and symptoms of anaphylaxis contributes to higher rates of diagnosis and treatment. Ongoing technological advancements in drug delivery systems like the development of enhanced auto-injectors with enhanced usability and reliability, improved patient convenience and compliance.
- The rising national healthcare expenditure is also driving the changes in emergency medical services (EMS), such as first responders training and upgrading the ambulances and emergency departments with appropriate medications and equipment. According to the Centers for Medicare & Medicaid Services report, the health spending share of GDP is forecast to grow from 18. 3 percent in 2021 to 19. 6 percent in 2031.
- The market share is also expanding due to the rising number of noncommunicable diseases like cardiovascular diseases and respiratory disorders. The World Health Organization’s (WHO) report 2023 shows that each year 17 million people die from a NCD before age 70 in low- and middle-income countries.
- The increasing application of telemedicine and remote patient monitoring technology presents an opportunity to integrate epinephrine management into virtual healthcare. This includes distance learning and teleconsultation for patients with allergies requiring epinephrine to promote access to care in the rural and underserved population.
- The integration of epinephrine delivery devices with wearable technology or smartphone applications can enhance usability, facilitate timely administration, and enable real-time monitoring of patient responses. Increasing collaborations between pharmaceuticals companies, healthcare providers, and advocacy groups is leading to innovative solutions.
Epinephrine News
The report covers the latest developments, updates, and trends impacting the global epinephrine market, providing stakeholders with timely and relevant information. This segment covers a wide array of news items, including the inauguration of new production facilities, advancements in epinephrine production technologies, strategic market expansions by key industry players, and significant mergers and acquisitions that impact the epinephrine price trend.
Latest developments in the epinephrine industry:
- In 2023, Nasus Pharma Ltd, a clinical stage biopharma company, announced the completion of its additional phase II clinical trial, confirming the efficacy and safety of its FMXIN002 intranasal epinephrine product.
- In 2023, American Regent, Inc., launched sulfite-free Epinephrine Injection, USP, which is indicated for emergency treatment of type I allergic reaction.
Product Description
Produced by adrenal glands, epinephrine is an adrenocortical hormone and neurotransmitter. It can be useful during certain medical procedures or during serious traumas to stop bleeding. It is used in an emergency medication in cases of anaphylaxis, asthma and cardiac arrest to treat the increased rate and pressure in the heart by causing vasoconstriction.
It acts to reverse symptoms such as swelling and hives, and low blood pressure, by constricting blood vessels. It is also added to local anesthetic solutions to prolong the effect of anesthetics by vasoconstriction at the injected site to decrease bleeding and retard absorption of the local anesthetic into the systemic circulation. It is also used for emergency CPR to stimulate the heart and produce a rise in perfusion to essential organs.
Regional Coverage
The report provides a detailed analysis of the epinephrine market across different regions, each with unique pricing dynamics influenced by localized market conditions, supply chain intricacies, and geopolitical factors. This includes price trends, price forecast and supply and demand trends for each region, along with spot prices by major ports. The report also provides coverage of ex-works, FOB, and CIF prices, as well as the key factors influencing the epinephrine price trend.
Global Epinephrine Price
The report offers a holistic view of the global epinephrine pricing trends in the form of epinephrine price charts, reflecting the worldwide interplay of supply-demand balances, international trade policies, and overarching economic factors that shape the market on a macro level. This comprehensive analysis not only highlights current price of epinephrine but also provides insights into historical price trends, enabling stakeholders to understand past fluctuations and their underlying causes.
The report also delves into price forecast models, projecting future price movements based on a variety of indicators such as expected changes in supply chain dynamics, anticipated policy shifts, and emerging market trends. By examining these factors, the report equips industry participants with the necessary tools to make informed strategic decisions, manage risks, and capitalize on market opportunities. Furthermore, it includes a detailed epinephrine demand analysis, breaking down regional variations and identifying key drivers specific to each geographic market, thus offering a nuanced understanding of the global pricing landscape.
Europe Epinephrine Price
European epinephrine prices are examined, highlighting the market-specific influences in the region, such as stringent environmental regulations, the competitive landscape, and import-export imbalances that significantly affect pricing structures.
This analysis can be extended to include detailed epinephrine price information for a comprehensive list of countries.
Region |
Countries Covered |
Europe |
Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal, and Greece, among other European countries. |
North America Epinephrine Price
The analysis of epinephrine prices in North America delves into the regional industry dynamics, encompassing the impact of local production capacities and the trade flows between North America and other significant global markets.
Specific epinephrine historical data within the United States and Canada can also be provided.
Region |
Countries Covered |
North America |
United States and Canada |
Middle East and Africa Epinephrine Price
The report explores the epinephrine pricing trends in the Middle East and Africa, considering factors like regional industrial growth, the availability of natural resources, and geopolitical tensions that uniquely influence market prices.
In addition to region-wise data, information on epinephrine prices for countries can also be provided.
Region |
Countries Covered |
Middle East & Africa |
Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco, among other Middle Eastern and African countries. |
Asia Pacific Epinephrine Price
The epinephrine pricing trends in Asia Pacific are examined, reflecting the role of the region as a major global production hub and consumer market, with price dynamics heavily influenced by supply chain efficiencies, regional demand surges, and policy shifts in major economies.
This epinephrine price analysis can be expanded to include a comprehensive list of countries within the region.
Region |
Countries Covered |
Asia Pacific |
China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand, among other Asian countries. |
Latin America Epinephrine Price
The analysis of epinephrine prices in Latin America provides a detailed overview, reflecting the unique market dynamics in the region influenced by economic policies, industrial growth, and trade frameworks.
This comprehensive review can be extended to include specific countries within the region.
Region |
Countries Covered |
Latin America |
Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru, among other Latin American countries. |
Report Coverage
Key Attributes |
Details |
Product Name |
Epinephrine |
Report Features |
Exploration of Historical Trends and Market Outlook, Industry Demand, Industry Supply, Gap Analysis, Challenges, Epinephrine Price Analysis, and Segment-Wise Assessment. |
Currency/Units |
US$ (Data can also be provided in local currency) or Metric Tons |
Region/Countries Covered |
The current coverage includes analysis at the global and regional levels only.
Based on your requirements, we can also customize the report and provide specific information for the following countries:
Asia Pacific: China, India, Indonesia, Pakistan, Bangladesh, Japan, Philippines, Vietnam, Thailand, South Korea, Malaysia, Nepal, Taiwan, Sri Lanka, Hongkong, Singapore, Australia, and New Zealand*
Europe: Germany, France, United Kingdom, Italy, Spain, Russia, Turkey, Netherlands, Poland, Sweden, Belgium, Austria, Ireland, Switzerland, Norway, Denmark, Romania, Finland, Czech Republic, Portugal and Greece*
North America: United States and Canada
Latin America: Brazil, Mexico, Argentina, Columbia, Chile, Ecuador, and Peru*
Middle East & Africa: Saudi Arabia, UAE, Israel, Iran, South Africa, Nigeria, Oman, Kuwait, Qatar, Iraq, Egypt, Algeria, and Morocco*
*The list of countries presented is not exhaustive. Information on additional countries can be provided if required by the client. |
Information Covered for Key Suppliers |
- Company Overview
- Business Description
- Product Portfolio
- Recent Trends and Developments
|
Customization Scope |
The report can be customized as per the requirements of the customer |
Report Price and Purchase Option |
Plan A: Monthly Updates - Annual Subscription
- Scope
- Historical Data for the Current Month
- Forecast for Next Month
- Total Deliverables Per Year: 12 (One Per Month)
- Includes: One PDF and Excel datasheet per month, Post Purchase Analyst Support throughout the year
Plan B: Quarterly Updates - Annual Subscription
- Scope
- Historical Data for the Current Quarter
- Forecast for Next Quarter
- Total Deliverables Per Year: 4 (One Per Quarter)
- Includes: One PDF and Excel datasheet per Quarter, Post Purchase Analyst Support throughout the year
Plan C: Biannually Updates - Annual Subscription
- Scope
- Historical Data for the Current Half
- Forecast for the Next Half
- Total Deliverables Per Year: 2 (One Per 6 Months)
- Includes: One PDF and Excel datasheet per Half, Post Purchase Analyst Support throughout the year
|
Post-Sale Analyst Support |
360-degree analyst support after report delivery |
Delivery Format |
PDF and Excel through email (We can also provide the editable version of the report in PPT/Word format on special request) |
Key Benefits for Stakeholders:
- IMARC’s report presents a detailed analysis of epinephrine pricing, covering global and regional trends, spot prices at key ports, and a breakdown of Ex Works, FOB, and CIF prices.
- The study examines factors affecting epinephrine price trend, including raw material costs, supply-demand shifts, geopolitical impacts, and industry developments, offering insights for informed decision-making.
- The competitive landscape review equips stakeholders with crucial insights into the latest market news, regulatory changes, and technological advancements, ensuring a well-rounded, strategic overview for forecasting and planning.
- IMARC offers various subscription options, including monthly, quarterly, and biannual updates, allowing clients to stay informed with the latest market trends, ongoing developments, and comprehensive market insights. The epinephrine price charts ensure our clients remain at the forefront of the industry.